Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 10 to 17

Tegileridine for postoperative pain after adolescent scoliosis surgery

Official title: Efficacy and Safety of Tegileridine on Postoperative Pain in Adolescent Patients Undergoing Scoliosis Correction Surgery: A Multicentre, Double-blind, Non-inferiority, Randomised Controlled Trial

Run by Peking Union Medical College Hospital · NCT07229495 · Data updated 2026-11-12

This trial tests whether Tegileridine can provide pain relief after spine surgery in teens as well as morphine, using a patient-controlled pump and comparing safety profiles.

More Scoliosis trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages10 Years to 17 Years
SexAll
Enrollment171 (estimated)
SponsorPeking Union Medical College Hospital
Academic / other
Locations6 sites (Zhengzhou, Henan and 5 other locations)
StatusRecruiting
StartedApril 8, 2026
Main results expectedOctober 30, 2027
Study endsDecember 30, 2027
Registry record updatedOctober 13, 2026
Trial IDNCT07229495 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adolescents aged 10 to less than 18 years undergoing posterior spinal fusion for idiopathic scoliosis, with ASA I–III, and whose guardians provide informed consent.

Probably not a fit

Patients who do not respond to opioids as expected or who have complications preventing analgesia may not experience a benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, randomized, double-blind, non-inferiority trial compares Tegileridine with morphine for postoperative analgesia in adolescents undergoing posterior spinal fusion for scoliosis. Participants receive a loading dose followed by a patient-controlled analgesia pump, with three arms: Tegileridine 20 μg/kg loading dose plus 1 μg/kg per bolus, Tegileridine 20 μg/kg loading dose plus 2 μg/kg per bolus, and morphine 60 μg/kg loading dose plus 20 μg/kg per bolus. The study aims to determine if Tegileridine is not worse than morphine in the first 24–48 hours post-surgery and to compare adverse effects such as sedation and nausea. The trial is designed to assess both efficacy and safety in the adolescent population, with blinding maintained for participants and investigators.

Why it matters

Potential benefit: If Tegileridine proves non-inferior and safer, it could offer effective pain control with fewer side effects for teens after spine surgery.

How similar studies have gone: Previous studies in opioid analgesia for postoperative pain have shown that non-inferiority trials can identify alternatives with comparable efficacy and improved safety profiles.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 10 years to less than 18 years.
* Scheduled to undergo posterior spinal fusion (PSF) surgery for adolescent idiopathic scoliosis under general anesthesia.
* American Society of Anesthesiologists (ASA) physical status classification I to III.
* The participant and their parent or legal guardian voluntarily provide written informed consent prior to any study-related procedures.

Exclusion Criteria:

* Baseline room-air oxygen saturation (SpO2) \< 90% at rest, acute or severe bronchial asthma.
* History of severe cardiovascular or cerebrovascular disease, such as myocardial infarction, unstable angina, second-degree or higher atrioventricular block, NYHA Class III or higher heart failure, or stroke.
* Known or suspected gastrointestinal obstruction, including paralytic ileus.
* Known hypersensitivity to opioids or any component of the study drug formulation.
* Severe cognitive impairment or uncontrolled psychiatric disorders (e.g., active schizophrenia) that preclude the patient's ability to comprehend the NRS or independently operate the patient-controlled analgesia (PCA) pump.
* Diagnosis of neuromuscular scoliosis or presence of any other chronic pain condition that may interfere with postoperative pain assessment.
* Chronic use of opioid analgesics, or use of any long-acting analgesics within 48 hours prior to surgery (short-acting non-opioid analgesics are permitted but must be discontinued at least 12 hours preoperatively).
* Planned postoperative admission to the intensive care unit (ICU).

Where it's running

  • Peking Union Medical College Hospital
    Beijing, China
    Recruiting
  • Henan Provincial People's Hospital
    Zhengzhou, Henan, China
    Not yet recruiting
  • The First Affiliated Hospital of Nanchang University
    Nanchang, Jiangxi, China
    Not yet recruiting
  • Beijing Chao-yang Hospital, Capital Medical University
    Beijing, China
    Not yet recruiting
  • Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
    Shanghai, China
    Not yet recruiting
  • Shanghai Children's Medical Centre, School of Medicine, Shanghai Jiao Tong University
    Shanghai, China
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.